PCRX
Pacira BioScienc (PCRX)
NASDAQ
$25.60+$0.06 (+0.23%)
Price as of Jul 14, 2026 5:50 AM EDT
  • $1.0B
    Market Cap
  • 9.57%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 34
Valuation
PCRX
vs History
vs S&P 500
Profitability
-0
Growth
-0
Low Earnings Volatility
0

Momentum Score

Score: 9
Valuation
PCRX
vs History
vs S&P 500
3-Month Momentum
0.73%
12-Month Momentum
2.27%
3-Month Risk Adjusted Momentum
5.25%
12-Month Risk Adjusted Momentum
6.28%

True Yield

N/A
Valuation
PCRX
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
10.94%
Net Debt Paydown Yield
-7.67%

Financial Health Score

Score: 72
Valuation
PCRX
vs History
vs S&P 500
Ohlson's O-Score
7